Naperville, IL -- (SBWIRE) -- 11/10/2014 -- Reportstack, provider of premium market research reports announces the addition of Global Overactive Bladder Therapeutics Market 2014-2018 market report to its offering
About Overactive Bladder
Overactive bladder is a urological condition associated with urination problems. The condition is characterized by bladder storage symptoms such as urgency, change in frequency of urination, nocturia, or urinary incontinence. It is also known as overactive bladder syndrome. Although it is not a life-threatening condition, it is often stigmatized and debilitating. Some of the important symptoms of overactive bladder are urinary urgency and incontinence. The pathophysiology of overactive bladder is not characterized completely. The symptoms of overactive bladder can last for a lifetime or it can relapse and remit. The problem can be resolved through treatment. Overactive bladder can affect a person irrespective of the gender. The reason is the abnormal contraction of the urinary detrusor muscle of the bladder. In addition, overactive bladder can be related to neurological diseases such as Parkinson's disease and multiple sclerosis.
Analysts forecast the Global Overactive Bladder Therapeutics market to grow at a CAGR of 1.14 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Overactive Bladder Therapeutics market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various generic and branded therapies used in the treatment of overactive bladder, which include:
Anti-muscarinic Agent
Beta-3-Adrenergic Receptor Agonist
Global Overactive Bladder Therapeutics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Overactive Bladder Therapeutics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions:
- Americas
- APAC
- EMEA
Key Vendors:
- Actavis
- Allergan
- Astellas Pharma
- Pfizer
Other Prominent Vendors:
- Addex Therapeutics
- AltheRx Pharmaceuticals
- American Oriental Bioengineering
- Antares Pharma
- Apogepha Arzneimittel
- Auxilium Pharmaceuticals
- Bayer
- elbion
- FemmePharma
- Ferring Pharmaceuticals
- GlaxoSmithKline
- Hisamitsu Pharmaceutical
- Hydra Biosciences
- Ion Channel Innovations
- Ipsen
- Janssen
- Kissei Pharma
- Kwang Dong Pharmaceutical
- KYORIN Pharma
- Laboratorios SALVAT
- LG Life Sciences
- Lipella Pharmaceuticals
- Merck
- Motif BioSciences
- Mylan
- Novartis
- Ono Pharmaceuticals
- Ranbaxy Laboratories
- Recordati
- Sanofi
- Sunovion
- Takeda Pharmaceutical
- TARIS BioMedical
- Teva Pharmaceutical
- TheraVida
- Toray Industries
- Urigen Pharmaceuticals
Market Driver:
- Rise in Geriatric Population
- For a full, detailed list, view our report
Market Challenge:
- Difficulty in Disease Diagnosis
- For a full, detailed list, view our report
Market Trend:
- Increase in Awareness
- For a full, detailed list, view our report
Key Questions Answered in this Report:
- What will the market size be in 2018 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
Complete report is available
http://www.reportstack.com/product/183422/global-overactive-bladder-therapeutics-market-2014-2018.html
Contact:
Roger Campbell
roger@reportstack.com
Naperville
Illinois
United States
Ph: 888-789-6604